Logo image of ZS3.DE

FINECOBANK SPA (ZS3.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ZS3 - IT0000072170 - Common Stock

22.01 EUR
+0.45 (+2.09%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ZS3. ZS3 was compared to 102 industry peers in the Banks industry. ZS3 has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, ZS3 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ZS3 was profitable.
ZS3 had a negative operating cash flow in the past year.
Each year in the past 5 years ZS3 has been profitable.
ZS3 had a positive operating cash flow in 4 of the past 5 years.
ZS3.DE Yearly Net Income VS EBIT VS OCF VS FCFZS3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

ZS3's Return On Assets of 2.78% is amongst the best of the industry. ZS3 outperforms 99.12% of its industry peers.
ZS3 has a better Return On Equity (43.83%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 2.78%
ROE 43.83%
ROIC N/A
ROA(3y)1.63%
ROA(5y)1.41%
ROE(3y)25.83%
ROE(5y)23.74%
ROIC(3y)N/A
ROIC(5y)N/A
ZS3.DE Yearly ROA, ROE, ROICZS3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 39.56%, ZS3 belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
ZS3's Profit Margin has improved in the last couple of years.
ZS3 does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 39.56%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.75%
PM growth 5Y3.63%
GM growth 3YN/A
GM growth 5YN/A
ZS3.DE Yearly Profit, Operating, Gross MarginsZS3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

ZS3 does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZS3 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ZS3 has been increased compared to 5 years ago.
Compared to 1 year ago, ZS3 has an improved debt to assets ratio.
ZS3.DE Yearly Shares OutstandingZS3.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ZS3.DE Yearly Total Debt VS Total AssetsZS3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

ZS3 has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ZS3 (1.03) is better than 71.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.5%
ZS3.DE Yearly LT Debt VS Equity VS FCFZS3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ZS3.DE Yearly Current Assets VS Current LiabilitesZS3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.71% over the past year.
The Earnings Per Share has been growing by 17.65% on average over the past years. This is quite good.
ZS3 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.48%.
Measured over the past years, ZS3 shows a quite strong growth in Revenue. The Revenue has been growing by 13.61% on average per year.
EPS 1Y (TTM)3.71%
EPS 3Y19.56%
EPS 5Y17.65%
EPS Q2Q%-4.25%
Revenue 1Y (TTM)2.48%
Revenue growth 3Y14.23%
Revenue growth 5Y13.61%
Sales Q2Q%-0.44%

3.2 Future

The Earnings Per Share is expected to grow by 5.38% on average over the next years.
ZS3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.20% yearly.
EPS Next Y-3.75%
EPS Next 2Y1.06%
EPS Next 3Y3.4%
EPS Next 5Y5.38%
Revenue Next Year-0.38%
Revenue Next 2Y2.83%
Revenue Next 3Y4.34%
Revenue Next 5Y6.2%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZS3.DE Yearly Revenue VS EstimatesZS3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ZS3.DE Yearly EPS VS EstimatesZS3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.57, the valuation of ZS3 can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ZS3 indicates a rather expensive valuation: ZS3 more expensive than 89.47% of the companies listed in the same industry.
ZS3's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.77.
The Price/Forward Earnings ratio is 20.20, which indicates a rather expensive current valuation of ZS3.
ZS3's Price/Forward Earnings ratio is rather expensive when compared to the industry. ZS3 is more expensive than 83.33% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.35. ZS3 is around the same levels.
Industry RankSector Rank
PE 20.57
Fwd PE 20.2
ZS3.DE Price Earnings VS Forward Price EarningsZS3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZS3.DE Per share dataZS3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.17
EPS Next 2Y1.06%
EPS Next 3Y3.4%

4

5. Dividend

5.1 Amount

ZS3 has a Yearly Dividend Yield of 3.35%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.31, ZS3 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.00, ZS3 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.35%

5.2 History

On average, the dividend of ZS3 grows each year by 17.06%, which is quite nice.
Dividend Growth(5Y)17.06%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

ZS3 pays out 49.15% of its income as dividend. This is a bit on the high side, but may be sustainable.
ZS3's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP49.15%
EPS Next 2Y1.06%
EPS Next 3Y3.4%
ZS3.DE Yearly Income VS Free CF VS DividendZS3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
ZS3.DE Dividend Payout.ZS3.DE Dividend Payout, showing the Payout Ratio.ZS3.DE Dividend Payout.PayoutRetained Earnings

FINECOBANK SPA

FRA:ZS3 (12/19/2025, 7:00:00 PM)

22.01

+0.45 (+2.09%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-04 2026-02-04/amc
Inst Owners78.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.46B
Revenue(TTM)2.49B
Net Income(TTM)983.67M
Analysts80
Price Target23.55 (7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.35%
Yearly Dividend0.74
Dividend Growth(5Y)17.06%
DP49.15%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.07%
Min EPS beat(2)-0.99%
Max EPS beat(2)3.14%
EPS beat(4)3
Avg EPS beat(4)2.41%
Min EPS beat(4)-0.99%
Max EPS beat(4)5.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.54%
Min Revenue beat(2)0.21%
Max Revenue beat(2)0.86%
Revenue beat(4)4
Avg Revenue beat(4)45.1%
Min Revenue beat(4)0.21%
Max Revenue beat(4)177.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.22%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.46%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.57
Fwd PE 20.2
P/S 5.41
P/FCF N/A
P/OCF N/A
P/B 6
P/tB 6.35
EV/EBITDA N/A
EPS(TTM)1.07
EY4.86%
EPS(NY)1.09
Fwd EY4.95%
FCF(TTM)-0.99
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS4.07
BVpS3.67
TBVpS3.47
PEG (NY)N/A
PEG (5Y)1.17
Graham Number9.4
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 43.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 39.56%
GM N/A
FCFM N/A
ROA(3y)1.63%
ROA(5y)1.41%
ROE(3y)25.83%
ROE(5y)23.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.75%
PM growth 5Y3.63%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 86.18%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.5%
ROIC/WACCN/A
Cap/Depr(3y)59.81%
Cap/Depr(5y)70.1%
Cap/Sales(3y)0.97%
Cap/Sales(5y)1.36%
Profit Quality(3y)88.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.71%
EPS 3Y19.56%
EPS 5Y17.65%
EPS Q2Q%-4.25%
EPS Next Y-3.75%
EPS Next 2Y1.06%
EPS Next 3Y3.4%
EPS Next 5Y5.38%
Revenue 1Y (TTM)2.48%
Revenue growth 3Y14.23%
Revenue growth 5Y13.61%
Sales Q2Q%-0.44%
Revenue Next Year-0.38%
Revenue Next 2Y2.83%
Revenue Next 3Y4.34%
Revenue Next 5Y6.2%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.66%
EBIT Next 3Y4.75%
EBIT Next 5YN/A
FCF growth 1Y-300.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-285.13%
OCF growth 3YN/A
OCF growth 5YN/A

FINECOBANK SPA / ZS3.DE FAQ

What is the ChartMill fundamental rating of FINECOBANK SPA (ZS3.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ZS3.DE.


What is the valuation status for ZS3 stock?

ChartMill assigns a valuation rating of 1 / 10 to FINECOBANK SPA (ZS3.DE). This can be considered as Overvalued.


How profitable is FINECOBANK SPA (ZS3.DE) stock?

FINECOBANK SPA (ZS3.DE) has a profitability rating of 4 / 10.


What is the financial health of FINECOBANK SPA (ZS3.DE) stock?

The financial health rating of FINECOBANK SPA (ZS3.DE) is 1 / 10.


Can you provide the expected EPS growth for ZS3 stock?

The Earnings per Share (EPS) of FINECOBANK SPA (ZS3.DE) is expected to decline by -3.75% in the next year.